-+ 0.00%
-+ 0.00%
-+ 0.00%

Atrium Therapeutics corrects post-offering shares outstanding to 21,571,507

PUBT·10/09/2026 10:20:03
Atrium Therapeutics corrects post-offering shares outstanding to 21,571,507
  • Atrium Therapeutics filed an amended 8-K to correct the previously disclosed post-offering share count.
  • Updated figure: 21,571,507 common shares outstanding following the PIPE financing announced on Oct. 7, 2026.
  • PIPE terms unchanged: 5,170,384 common shares sold, pre-funded warrants for up to 1,134,930 additional shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atrium Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-418417), on October 09, 2026, and is solely responsible for the information contained therein.